BREAST CARCINOMA
Clinical trials for BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tamoxifen gel vs. pill: can a cream lower breast cancer risk?
Disease control TerminatedThis study tested whether a tamoxifen skin gel works as well as the standard tamoxifen pill to lower breast cancer risk in women with atypical hyperplasia or lobular carcinoma in situ (LCIS). About 65 women were enrolled, but the study was stopped early. The goal was to see short…
Matched conditions: BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Common diabetes and antibiotic drugs tested against cancer, but study stopped early
Disease control TerminatedThis study tested whether combining metformin (a diabetes drug) with doxycycline (an antibiotic) could help treat localized breast or uterine cancer. It involved 29 adults who were scheduled for surgery. The goal was to see if the drugs could change certain markers in the tumor's…
Matched conditions: BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: BREAST CARCINOMA
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
Genetic risk tool tested for breast cancer in minority women
Knowledge-focused TerminatedThis study looked at whether adding a genetic risk score to standard breast cancer risk assessments helps African American and Hispanic women decide about extra screening or prevention. The study enrolled 19 women at higher risk for breast cancer. The goal was to see if personali…
Matched conditions: BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Brain scans and VR aim to decode cancer pain
Knowledge-focused TerminatedThis study explored whether a special brain scan (fNIRS) can measure pain in cancer patients and survivors. Researchers also tested if virtual reality (VR) can help reduce pain by distracting the brain. The goal was to create better, non-drug ways to assess and manage cancer pain…
Matched conditions: BREAST CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC